The Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry is on a steady growth trajectory, with projections indicating a valuation of US$ 39.5 billion by 2028. This market is experiencing substantial demand, marked by an average compound annual growth rate (CAGR) of 4.7% from 2022 to 2028. In 2022, the market is already set to …
Tag Archives: Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry
Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry to Soar to US$ 39.5 Billion by 2028, with a CAGR of 4.7% | Says FMI
The Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry is poised for remarkable growth, with expectations to reach a substantial valuation of US$ 39.5 billion by 2028. This surge reflects an average compound annual growth rate (CAGR) of 4.7% from 2022 to 2028. In 2022, the market is already on the path to reaching an …